Youjun Xiao

1.1k total citations
35 papers, 919 citations indexed

About

Youjun Xiao is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Youjun Xiao has authored 35 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Rheumatology and 13 papers in Oncology. Recurrent topics in Youjun Xiao's work include Rheumatoid Arthritis Research and Therapies (11 papers), Signaling Pathways in Disease (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Youjun Xiao is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Signaling Pathways in Disease (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Youjun Xiao collaborates with scholars based in China and United States. Youjun Xiao's co-authors include Liuqin Liang, Hanshi Xu, Maohua Shi, Xiuyan Yang, Qian Qiu, Yaoyao Zou, Mingcheng Huang, Shan Zeng, Siqi Xu and Zhongping Zhan and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Cancer Research.

In The Last Decade

Youjun Xiao

33 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youjun Xiao China 18 468 268 233 215 168 35 919
Maohua Shi China 22 612 1.3× 242 0.9× 408 1.8× 242 1.1× 224 1.3× 35 1.2k
Yaoyao Zou China 19 526 1.1× 231 0.9× 228 1.0× 224 1.0× 158 0.9× 32 947
Jun‐Geol Ryu South Korea 16 316 0.7× 170 0.6× 398 1.7× 85 0.4× 241 1.4× 23 833
Davoud Rostamzadeh Iran 16 420 0.9× 133 0.5× 264 1.1× 183 0.9× 149 0.9× 35 1.0k
Rongfen Huo China 17 457 1.0× 152 0.6× 290 1.2× 128 0.6× 102 0.6× 24 825
Hye‐Jwa Oh South Korea 18 345 0.7× 355 1.3× 674 2.9× 95 0.4× 256 1.5× 26 1.2k
C Gasparini Italy 15 251 0.5× 121 0.5× 303 1.3× 172 0.8× 131 0.8× 25 849
Fiorella Petrelli Italy 8 214 0.5× 413 1.5× 166 0.7× 98 0.5× 111 0.7× 14 742
Ann Biehl United States 5 231 0.5× 261 1.0× 359 1.5× 50 0.2× 283 1.7× 8 970
Ji‐Hyeon Ju South Korea 15 210 0.4× 171 0.6× 317 1.4× 79 0.4× 184 1.1× 23 729

Countries citing papers authored by Youjun Xiao

Since Specialization
Citations

This map shows the geographic impact of Youjun Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youjun Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youjun Xiao more than expected).

Fields of papers citing papers by Youjun Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youjun Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youjun Xiao. The network helps show where Youjun Xiao may publish in the future.

Co-authorship network of co-authors of Youjun Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Youjun Xiao. A scholar is included among the top collaborators of Youjun Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youjun Xiao. Youjun Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiangyang, Linsen Ye, Yuhao Zheng, et al.. (2025). FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus. Cellular and Molecular Immunology. 22(8). 889–900. 1 indexed citations
3.
Liu, Yingli, Di Liu, Yu Kuang, et al.. (2024). Coptisine inhibits aggressive and proliferative actions of fibroblast like synoviocytes and exerts a therapeutic potential for rheumatoid arthritis. International Immunopharmacology. 128. 111433–111433. 7 indexed citations
5.
Liu, Suling, Qian Qiu, Di Fu, et al.. (2024). Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease. Arthritis Research & Therapy. 26(1). 184–184. 6 indexed citations
6.
Xu, Siqi, Di Liu, Yu Kuang, et al.. (2023). Long Noncoding RNA HAFML Promotes Migration and Invasion of Rheumatoid Fibroblast-like Synoviocytes. The Journal of Immunology. 210(2). 135–147. 6 indexed citations
8.
Xu, Meilin, Siqi Xu, Wei Lin, et al.. (2022). Myricitrin inhibits fibroblast-like synoviocyte-mediated rheumatoid synovial inflammation and joint destruction by targeting AIM2. Frontiers in Pharmacology. 13. 905376–905376. 15 indexed citations
9.
Li, Ruiru, Wei Lin, Yu Kuang, et al.. (2022). cGAS/STING signaling in the regulation of rheumatoid synovial aggression. Annals of Translational Medicine. 10(8). 431–431. 20 indexed citations
10.
Wang, Jingnan, Ruiru Li, Cuicui Wang, et al.. (2021). Increased long noncoding RNA LINK-A contributes to rheumatoid synovial inflammation and aggression. JCI Insight. 6(23). 15 indexed citations
11.
Kuang, Yu, Ruiru Li, Jingnan Wang, et al.. (2021). Nitidine chloride inhibits fibroblast like synoviocytes-mediated rheumatoid synovial inflammation and joint destruction by targeting KCNH1. International Immunopharmacology. 101(Pt A). 108273–108273. 9 indexed citations
12.
Wang, Jingnan, Ruiru Li, Haobo Lin, et al.. (2019). Accumulation of cytosolic dsDNA contributes to fibroblast-like synoviocytes-mediated rheumatoid arthritis synovial inflammation. International Immunopharmacology. 76. 105791–105791. 58 indexed citations
13.
Xu, Siqi, Youjun Xiao, Shan Zeng, et al.. (2017). Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflammation Research. 67(3). 233–243. 36 indexed citations
14.
Zou, Yaoyao, Shan Zeng, Mingcheng Huang, et al.. (2017). Inhibition of 6‐phosphofructo‐2‐kinase suppresses fibroblast‐like synoviocytes‐mediated synovial inflammation and joint destruction in rheumatoid arthritis. British Journal of Pharmacology. 174(9). 893–908. 93 indexed citations
16.
Liang, Liuqin, Mingcheng Huang, Youjun Xiao, et al.. (2015). Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflammation Research. 64(3-4). 225–233. 44 indexed citations
17.
Yuan, Shiwen, Dongying Chen, Youjun Xiao, et al.. (2015). Factors Associated with Erosive Arthritis in Rheumatoid Arthritis and Other Connective Tissue Diseases. JCR Journal of Clinical Rheumatology. 22(1). 22–29. 3 indexed citations
18.
Lian, Fan, Yu Wang, Youjun Xiao, et al.. (2015). Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis. Molecular Medicine Reports. 12(4). 5821–5827. 21 indexed citations
19.
Xiao, Youjun, Mengying Sun, Zhongping Zhan, et al.. (2014). Increased phosphorylation of ezrin is associated with the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Lara D. Veeken. 53(7). 1291–1300. 11 indexed citations
20.
Liang, Liuqin, Mingcheng Huang, Qian Qiu, et al.. (2013). [Modulation of RhoA/Rho kinase on migration, invasion and proliferation of fibroblast like synoviocytes from patients with rheumatoid arthritis].. PubMed. 93(17). 1345–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026